These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19374542)

  • 1. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer.
    de Araujo Souza PS; Sichero L; Maciag PC
    Future Oncol; 2009 Apr; 5(3):359-70. PubMed ID: 19374542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
    Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I alleles and cervical neoplasia.
    Visser JT; Hoogeboom BN; Reesink-Peters N; Klip H; Hepkema B; van Velde H; van der Zee AG; Daemen T
    J Infect Dis; 2003 May; 187(10):1675-6. PubMed ID: 12721951
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
    Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
    Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.
    Beskow AH; Gyllensten UB
    Int J Cancer; 2002 Oct; 101(6):526-31. PubMed ID: 12237892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host and viral genetics and risk of cervical cancer: a review.
    Hildesheim A; Wang SS
    Virus Res; 2002 Nov; 89(2):229-40. PubMed ID: 12445662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma.
    Yang YC; Chang TY; Chen TC; Chang SC; Lin WS; Lee YJ
    Hum Immunol; 2013 Jul; 74(7):882-7. PubMed ID: 23603311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
    Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
    Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
    Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.
    Mehta AM; Mooij M; Branković I; Ouburg S; Morré SA; Jordanova ES
    J Immunol Res; 2017; 2017():8913860. PubMed ID: 28280748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to HPV infection and cervical cancer.
    Maciag PC; Villa LL
    Braz J Med Biol Res; 1999 Jul; 32(7):915-22. PubMed ID: 10454752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer.
    Segat L; Crovella S; Comar M; Milanese M; Zanotta N; Fabris A; Trevisiol C; Rossi T; De Seta F; Campello C
    Hum Immunol; 2009 Jun; 70(6):436-9. PubMed ID: 19275921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between HPV infection and HLA-DQB1 alleles polymorphism in the cervical carcinogenesis in Uyghur women in southern Xinjiang].
    Guzalinuer A; Mihrinsa A; Zhang SQ; Li H; Gulishare N; Zhang GQ
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):492-6. PubMed ID: 21029690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
    Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
    J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.
    Mahmud SM; Robinson K; Richardson H; Tellier PP; Ferenczy AS; Roger M; Coutlee F; Franco EL
    J Infect Dis; 2007 Jul; 196(1):82-90. PubMed ID: 17538887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype.
    Arias-Pulido H; Joste N; Wheeler CM
    Genes Chromosomes Cancer; 2004 Aug; 40(4):277-84. PubMed ID: 15188450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
    Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.